Literature DB >> 11181100

Epilepsy and EEG findings in 18 males with fragile X syndrome.

M Sabaratnam1, P G Vroegop, S K Gangadharan.   

Abstract

Of the 24 males identified as having fragile X syndrome in the Northeast Essex screening programme, 25% had epilepsy. Epilepsy in individuals with fragile X syndrome is known to follow a benign course with seizures disappearing before the age of 20. However, half of our sample with a history of epilepsy continued to have seizures after the age of 20. We reviewed the EEG reports of 18 of the 24 individuals (aged between 13 and 63 years) including all six individuals with epilepsy. We had 32 EEG recordings from 18 subjects, with nine people having more than one recording at different points. The EEG showed a definite improvement in only five individuals. Three individuals who had serial recordings (one with epilepsy) showed no significant changes over time and the EEG of one subject with epilepsy deteriorated. The most common abnormal EEG findings were rhythmic theta activity (50%) and a slowing of background activity (28%). There were no characteristic features in the sleep EEGs performed on four subjects. The possible implications of these preliminary findings are discussed. Copyright 2001 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11181100     DOI: 10.1053/seiz.2000.0492

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  32 in total

Review 1.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

Review 2.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

3.  Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model.

Authors:  Shih-Chieh Chuang; Wangfa Zhao; Robert Bauchwitz; Qijiang Yan; Riccardo Bianchi; Robert K S Wong
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

Review 4.  Public Health Literature Review of Fragile X Syndrome.

Authors:  Melissa Raspa; Anne C Wheeler; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

5.  Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice.

Authors:  Teresa H Wen; Sonia Afroz; Sarah M Reinhard; Arnold R Palacios; Kendal Tapia; Devin K Binder; Khaleel A Razak; Iryna M Ethell
Journal:  Cereb Cortex       Date:  2018-11-01       Impact factor: 5.357

Review 6.  Epilepsy and chromosomal abnormalities.

Authors:  Giovanni Sorge; Anna Sorge
Journal:  Ital J Pediatr       Date:  2010-05-03       Impact factor: 2.638

7.  Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.

Authors:  Jay R Gibson; Aundrea F Bartley; Seth A Hays; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

8.  Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.

Authors:  Catalina García-Nonell; Eugenia Rigau Ratera; Susan Harris; David Hessl; Michele Y Ono; Nicole Tartaglia; Emily Marvin; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

9.  Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Development       Date:  2008-06-25       Impact factor: 6.868

10.  Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron.

Authors:  Steven R Young; Shih-Chieh Chuang; Wangfa Zhao; Robert K S Wong; Riccardo Bianchi
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.